Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3744
PEPG
PepGen Inc. - Common Stock
2.40 USD-1.64%+20.60%+49.07%+86.05%166.01 M USD
3746
EQ
Equillium, Inc. - Common Stock
2.62 USD-5.07%-15.21%-5.42%+539.02%165.65 M USD
3762
NRXP
NRX Pharmaceuticals, Inc. - Common Stock
4.46 USD+3.00%+12.06%+11.22%+150.56%161.58 M USD
3766
YDES
YD Bio Limited - Ordinary Shares
2.27 USD+7.08%+17.62%-15.93%-71.63%160.69 M USD

Frequently asked questions about ADC Therapeutics SA Common Shares

What is the ADC Therapeutics SA Common Shares stock price today?

The current price of ADC Therapeutics SA Common Shares (ADCT) is 1.29. Over the past 24 hours, the stock has changed by +4.03%. Follow the ADCT chart for real-time price dynamics.

What is the stock ticker of ADC Therapeutics SA Common Shares?

ADC Therapeutics SA Common Shares trades under the ticker ADCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is ADC Therapeutics SA Common Shares stock going up?

ADCT has changed by +3.20% over the last week, +26.47% over the last month, and -58.39% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does ADC Therapeutics SA Common Shares have?

As of the latest available data, ADC Therapeutics SA Common Shares has 193 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy ADC Therapeutics SA Common Shares stock?

You can buy ADC Therapeutics SA Common Shares (ADCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in ADC Therapeutics SA Common Shares stock?

Investing in ADC Therapeutics SA Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADCT chart and related analysis on metatrader.com as part of your research.

News